GlassScriptPhysician profile
Donika K Patel
NPI 1508006776
$7,576.51
in general payments reported to CMS, 2019-2025
67 companies · $1,668 in 2025
The $1,668 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,576 · 2020: $568 · 2021: $554 · 2022: $941 · 2023: $938 · 2024: $1,332 · 2025: $1,668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,835 · Education: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,834.51 |
| Education | $102.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $856.04 | 2021-2025 | |
| Ucb, INC. | $650.81 | 2019-2025 | Rystiggo, Briviact, Fintepla |
| Biogen, INC. | $492.82 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Novartis Pharmaceuticals Corporation | $414.80 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $388.37 | 2019-2025 | Ultomiris, Soliris |
| Alnylam Pharmaceuticals INC. | $321.13 | 2019-2025 | Onpattro |
| Acadia Pharmaceuticals INC | $296.51 | 2019-2025 | Daybue, Nuplazid |
| Lundbeck LLC | $229.56 | 2019-2024 | Vyepti |
| Argenx US, INC. | $228.17 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Supernus Pharmaceuticals, INC. | $174.58 | 2019-2020 | |
| Ge Healthcare | $169.59 | 2019-2025 | |
| Sk Life Science, INC. | $161.06 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $149.41 | 2023-2025 | Wainua |
| Emd Serono, INC. | $147.56 | 2019-2025 | Mavenclad |
| Tg Therapeutics, INC. | $145.61 | 2025 |
Show all 67 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donika Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.